Letter to the Editor: "Alemtuzumab-Induced Thyroid Dysfunction Exhibits Distinctive Clinical and Immunological Features"
- PMID: 30977837
- DOI: 10.1210/jc.2018-02435
Letter to the Editor: "Alemtuzumab-Induced Thyroid Dysfunction Exhibits Distinctive Clinical and Immunological Features"
Comment in
-
Response to Letter to the Editor: "Alemtuzumab-Induced Thyroid Dysfunction Exhibits Distinctive Clinical and Immunological Features".J Clin Endocrinol Metab. 2019 Sep 1;104(9):3626-3627. doi: 10.1210/jc.2018-02593. J Clin Endocrinol Metab. 2019. PMID: 30977836 No abstract available.
Comment on
-
Alemtuzumab-Induced Thyroid Dysfunction Exhibits Distinctive Clinical and Immunological Features.J Clin Endocrinol Metab. 2018 Aug 1;103(8):3010-3018. doi: 10.1210/jc.2018-00359. J Clin Endocrinol Metab. 2018. PMID: 29878256 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical